Research examines whether financial challenges facing hospitals with large Medicare populations lead indirectly to cost shifting

Harvard researchers found evidence to suggest that hospitals with large shares of Medicare patients are at greater risk of being acquired, which can skew the market structure and lead to higher commercial prices.

Nick Hut August 17, 2021

Study: In price negotiations with hospitals, self-insured employers lack leverage

The vast difference in market power between hospitals and employers leaves the latter group with little recourse in negotiations, according to a new study.

Nick Hut July 29, 2021

Moving a 340B covered entity’s pharmacy enterprise to an LLC may prove beneficial, but it requires a feasibility study

University of Utah Hospitals and Clinics (UUHC) in Salt Lake City performed research to assess the feasibility of moving its 340B covered-entity pharmacy enterprise to a Limited Liability Corporation (LLC), with a focus on risks that should be factored into the decision. Other organizations that are considering such a move could benefit from adopting UUHC’s assessment approach.

Nathan Hagen, PharmD, MS July 21, 2021

Healthcare News of Note: More healthcare organizations mandating that employees receive the COVID-19 vaccine

Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles: COVID-19 vaccine mandates become more popular among healthcare organizations, hospitals continue to skirt price transparency rules, and healthcare workers get help in coping with trauma.

Deborah Filipek June 22, 2021

Hospitals not adhering to CMS’s cost transparency rule may eventually find their public images tarnished by their noncompliance

Hospitals could lose patients and their good reputations if CMS makes public the names of those noncompliant with the latest price transparency rule.

Shawn Stack May 26, 2021

Congress seeks stepped-up hospital price transparency enforcement as compliance issues continue to emerge

The bipartisan leadership of a congressional committee is urging HHS to enforce price transparency rules more stringently.

Nick Hut April 15, 2021

3 questions with Katie Gilfillan: Why it’s time for the healthcare industry to address cost effectiveness of health

HFMA’s director of professional practice and clinical relationships discusses the importance of the Association’s Cost Effectiveness of Health event.

Deborah Filipek March 29, 2021

HHS delays implementation of rule requiring FQHCs to provide insulin, epinephrine at 340B prices

HHS has postponed a Trump administration regulation that would require federally qualified health centers to make certain drugs more affordable for low-income patients and will consider whether to withdraw the rule altogether.

Nick Hut March 24, 2021

How a health system prepared to comply with CMS’s new price transparency rule

The efforts of one health system to meet state and federal price transparency regulations shows the benefit of integrating transparency efforts into a broader organizational strategy.

Elizabeth Barker March 12, 2021

SVP Rick Gundling recaps new workshops, Biden and surprise bills

Rick Gundling, HFMA’s senior vice president of professional practice, talks about the Association's education plans for 2021 and comments on some hot topics in healthcare.

Brad Dennison March 1, 2021
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-leaderboard' ); } );